Using haematopoietic growth factors to increase dose intensity has not consistently improved survival [103] but may limit the morbidity of myelosuppression. Prophylactic antibiotics are recommended for patients at risk of neutropenic sepsis [121] but care should be taken that the chosen antibiotic does ...
Surviving sepsis campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 Intensive Care Med, 43 (3) (2017), pp. 304-377 CrossrefView in ScopusGoogle Scholar 18 Royal College of Physicians (UK) National Early Warning Score (NEWS) standardising the assessment of acute-...